Additionally, the volume injected and the administration via autoinjector may cause mechanical distension of tissue, potentially triggering discomfort
Compounded drugs generally arent vetted for safety and effectiveness as rigorously as standard drugs
Weight loss injections represent a significant advancement in obesity medicine, utilizing medications from two main classes: glucagon-like peptide-1 (GLP-1) receptor agonists and dual GIP/GLP-1 receptor agonists
This enzyme, an AMPK-dependent adipose tissue triglyceride lipase, is positively associated with the prevention of obesity
Several strategies can reduce side effects or extend the effective duration of each dose without changing the injection schedule
Peake J, Nosaka K, Suzuki K